RCM
AXN

Rotella Capital Management’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Rotella Capital Management’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-25,065
Closed -$17K – 347
2015
Q4 		$17K Sell
25,065
-6,121
-20% -$7.69K 0.02% 394
2015
Q3 		$46K Buy
31,186
+687
+2% +$1.08K 0.01% 498
2015
Q2 		$53K Buy
+30,499
New +$54.3K 0.04% 365

Other funds holding AXN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
MA
MUFG Americas New York $4.04B AUM 12.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rotella Capital Management's AXN Position: Q1 2016 in Review

Rotella Capital Management sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q1 2016, closing a stake of 25,065 shares — an estimated $17K sold.

Rotella Capital Management first reported a position in AXN in Q2 2015 and held it in 3 quarters. The position peaked at $53K in Q2 2015. 11 funds tracked by Wall St. Rank hold AXN as of Q1 2016.

  • Rotella Capital Management reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 25,065 Aoxing Pharmaceutical Company Inc. shares in Q1 2016, an estimated $17K.
  • Rotella Capital Management first reported a position in Aoxing Pharmaceutical Company Inc. in Q2 2015 and held it in 3 quarters.
  • Rotella Capital Management's Aoxing Pharmaceutical Company Inc. position peaked at $53K in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.